In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”.  YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments. Rhett Alden is the chief technology officer for health and commercial markets at Elsevier. This podcast is brought to you by <a href='https://www.relx.com'>RELX</a>.

In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”. YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments. Rhett Alden is the chief technology officer for health and commercial markets at Elsevier. This podcast is brought to you by RELX.

In this episode, YS Chi talks to Rhett Alden who joined Elsevier with “the idea, the expectation, that we’re really going to do something significant in the healthcare space to improve patients’ lives”.&nbsp; YS asks Rhett how it was possible to make such quick progress with the Covid vaccines, how to continue the push for more open access to information and how to build trust. Rhett shares his insights on all the possibilities that come with bringing different large data sets together to better understand patients, the exciting developments in oncology and the latest tools that are helping doctors find the best cancer treatments. Rhett Alden is the chief technology officer for health and commercial markets at Elsevier. This podcast is brought to you by <a href="https://www.relx.com" rel="noopener noreferrer">RELX</a>.

Rhett Alden - Improving patients' lives

In each episode of Unique Contributions, we bring you closer to some of the most interesting people from around our business working on industry-shaping issues that matter. We explore how they and we collectively as a business, create a positive impact on society through our knowledge, resources and skills. This is what we call our “unique contributions”. Join our host YS Chi, director of corporate affairs at RELX and Chairman of Elsevier, as he dives deep into conversations with some of his friends and colleagues. Thank you to our listeners for tuning in. You can check back here for a new episode each week.&nbsp; This podcast is brought to you by RELX, a global provider of information-based analytics and decision tools for professional and business customers, enabling them to make better decisions, get better results and be more productive. Our purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve justice and fair results for their clients; businesses and governments prevent fraud; consumers access financial services and get fair prices on insurance; and customers learn about markets and complete transactions. Our purpose guides our actions beyond the products that we develop. It defines us as a company. Every day across RELX our employees are inspired to undertake initiatives that make unique contributions to society and the communities in which we operate.

Society & Culture

Business

Management

In each episode of Unique Contributions, we bring you closer to some of the most interesting people from around our business working on industry-shaping issues that matter. We explore how they and we collectively as a business, create a positive impact on society through our knowledge, resources and skills. This is what we call our “unique contributions”. Join our host YS Chi, director of corporate affairs at RELX and Chairman of Elsevier, as he dives deep into conversations with some of his friends and colleagues. Thank you to our listeners for tuning in. You can check back here for a new episode each week.  This podcast is brought to you by RELX, a global provider of information-based analytics and decision tools for professional and business customers, enabling them to make better decisions, get better results and be more productive. Our purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve justice and fair results for their clients; businesses and governments prevent fraud; consumers access financial services and get fair prices on insurance; and customers learn about markets and complete transactions. Our purpose guides our actions beyond the products that we develop. It defines us as a company. Every day across RELX our employees are inspired to undertake initiatives that make unique contributions to society and the communities in which we operate.

Share Rhett Alden - Improving patients' lives

Sign up to save your podcasts

Rhett Alden - Improving patients' lives

Rhett Alden - Improving patients' lives

More shows like Unique Contributions

Masters in Business

The a16z Show

Invest Like the Best with Patrick O'Shaughnessy

Once Upon A Crime

Coffee House Shots

Capital Allocators – Inside the Institutional Investment Industry

Value Investing with Legends

Human Monsters

Money Maze Podcast

The Memo by Howard Marks

The Podcast of the Lotus Eaters

Business Breakdowns

Inhuman: A True Crime Podcast

Behind the Balance Sheet

In Good Company with Nicolai Tangen